Immunotherapy Horizons in Colorectal Cancer

The "Immunotherapy Horizons in Colorectal Cancer" series provides an in-depth exploration of how immune checkpoint inhibitors and molecular biomarkers are reshaping the management of both rectal and colon cancers. Chaired by Dr. Antonino Spinelli alongside an international panel of leading experts, this multi-episode program covers everything from biomarker-driven protocols and organ preservation to minimally invasive surgical integration, real-world evidence in MSI-h/dMMR tumors, and global health policies to ensure equitable access to innovative cancer care.